Results 231 to 240 of about 1,016,101 (284)

Harnessing Vδ1⁺ T cells for next-generation immunotherapy: from mechanistic insights to clinical translation. [PDF]

Front Immunol
Wang F, Zhao J, Zhang T, Shi J.
europepmc   +1 more source

Advances in research on layered double hydroxides for biomedical applications

Smart Molecules, EarlyView.
Layered double hydroxides (LDHs) are pH‐responsive nanomaterials with broad biomedical applications. This review summarizes LDH synthesis methods and compares their advantages. It highlights LDHs' progress in cancer therapy, including chemo‐photothermal, chemo‐immunotherapy, and photodynamic‐immunotherapy combinations and their potential in bone repair.
Xinhui Yang, Zhiping Zhang, Zhao Wang, Hao Zhang, Yen Leng Pak, Yingying Jing, Yurong Guo, Fang Li, Xiao Wang, Quanxiang Han, Lei Yu, Xuejiao Li, Xing Gao, Jibin Song   +13 more
wiley   +1 more source

Rejuvenating endogenous antitumor immunity via a chimeric receptor-engineered oncolytic virus targeting tumor-associated macrophages. [PDF]

Sci Adv
Lin C, Li S, Lou R, Teng W, Tian Y, Feng C, Wang N, Rao Y, Qin Y, Li L, Huang X, Lin Y, Zhang J, Xia N, Huang C.   +14 more
europepmc   +1 more source

Advances in adoptive cell therapy for ovarian cancer. [PDF]

Front Immunol
Zhao N, An Y, Guo S, Xu Z, Shi H, Zhang Z.   +5 more
europepmc   +1 more source

A universally applicable toolbox for single-molecule quantification of chimeric antigen receptors using linker-resolved <i>d</i>STORM microscopy. [PDF]

Front Immunol
Michael J, Spieler P, Toppeta F, Gehrke L, Seifert N, Grams B, Seifert R, Einsele H, Hudecek M, Sauer M, Nerreter T.   +10 more
europepmc   +1 more source

Advances and challenges of chimeric antigen receptor T cell therapy in digestive system malignancies. [PDF]

World J Clin Oncol
Wang C, Zhang J, Chen ZK, Wang YG, Shi M.   +4 more
europepmc   +1 more source

Peptide Therapeutics for Solid Tumors: Functional Classes, AI-Enhanced Discovery and Clinical Advances. [PDF]

J Pept Sci
Liang J, Tang X, Li H, Fang Y, Jiang F.
europepmc   +1 more source

Metabolic activation using fructose-1,6-bisphosphate microparticles of non-virally LNP-generated CAR-macrophages induces anti-tumor immune responses.

J Mater Chem B
Suresh AP, Qian H, Uppin V, Thumsi A, Sun D, Jaggarapu MMCS, Mangal J, Inamdar S, Lu ZR, Parameswaran R, Acharya AP.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chimeric antigen receptors

Nature Biotechnology, 2020
openaire   +2 more sources